Security
DA32 Life Science Tech Acquisition Corp. Class A Common Stock · DALS
DALSNASDAQCommon stockHistorical · closed Jul 28, 2023CIK 1863294Updated Nov 16, 2026
DALS price & chart
Historical security
This listing closed Jul 28, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
balance sheet · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| AssetsUSD | 202,405,559Source | 202,680,392Source | 201,739,026Source | — | 204,984,219Source | 202,210,094Source | 203,855,661Source | 202,492,929Source |
| Current assets: | ||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 1,952,464Source | 1,101,032Source | 164,907Source | — | 1,605,403Source | — | 1,864,919Source |
| Assets, CurrentUSD | 1,200,694Source | 2,671,041Source | 1,539,407Source | — | 491,106Source | 2,155,398Source | 928,965Source | 2,468,243Source |
| LIABILITIES AND EQUITY | ||||||||
| LiabilitiesUSD | 6,184,005Source | 5,816,825Source | 5,903,274Source | — | 6,952,980Source | 5,907,045Source | 6,650,033Source | 5,886,516Source |
| Stockholders’ equity: | ||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 0Source | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | -4,400,052Source | -3,136,998Source | -4,164,813Source | — | -5,109,260Source | -3,697,516Source | -4,736,400Source | -3,394,152Source |
| Stockholders' Equity Attributable to ParentUSD | -4,399,487Source | -3,136,433Source | -4,164,248Source | -17,664Source | -5,108,695Source | -3,696,951Source | -4,735,835Source | -3,393,587Source |
| Liabilities and EquityUSD | 202,405,559Source | 202,680,392Source | 201,739,026Source | — | 204,984,219Source | 202,210,094Source | 203,855,661Source | 202,492,929Source |
| Current liabilities: | ||||||||
| Liabilities, CurrentUSD | 584,005Source | 216,825Source | 303,274Source | — | 1,352,980Source | 307,045Source | 1,050,033Source | 286,516Source |
| Accounts Payable, CurrentUSD | 1,176Source | — | 32Source | — | 0Source | 32,080Source | 1,326Source | — |
| Additional Financial Items | ||||||||
| Accrued Liabilities, CurrentUSD | 327,000Source | 126,912Source | 261,000Source | — | 432,000Source | 225,600Source | 419,963Source | 144,000Source |
cash flow · annual statements
| Line item | Q4 2022 | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Changes in operating assets and liabilities: | ||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | 1,518Source | -1,326Source | 32,080Source | 1,326Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | 0Source | -395,484Source | -259,516Source | -1,095,663Source |
| Cash flows from investing activities: | ||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | 0Source |
| Cash flows from financing activities: | ||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | 164,907Source | — | — | -70,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 861,235Source | 1,952,464Source | — | — | 303,772Source | 1,605,403Source | 699,256Source |
| Additional Financial Items | ||||||||
| General and Administrative ExpenseUSD | — | 324,864Source | 197,060Source | 509,857Source | 1,518Source | 309,994Source | 231,509Source | 1,350,078Source |
| Income Tax Expense (Benefit)USD | — | 191,669Source | 0Source | — | — | 328,947Source | 0Source | 542,667Source |
| Net Income (Loss) Attributable to ParentUSD | — | 385,802Source | -271,476Source | -467,297Source | -42,664Source | 825,611Source | -303,364Source | 599,215Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | 25,000Source | — | — | 0Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | 1,005,246Source | 9,351Source | 144,923Source | 0Source | 1,566,417Source | 30,010Source | 2,902,010Source |
| Gain (Loss) on Investments | — | — | — | — | —Source | — | — | — |
| Nonoperating Income (Expense) | — | — | — | — | — | —Source | —Source | — |
income statement · annual statements
| Line item | Q4 2022 | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | -427,775Source | -280,827Source | -612,220Source | -42,664Source | -411,859Source | -333,374Source | -1,760,128Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | 577,471Source | -271,476Source | — | — | 1,154,558Source | -303,364Source | 1,141,882Source |
| Income Tax Expense (Benefit)USD | — | 191,669Source | 0Source | — | — | 328,947Source | 0Source | 542,667Source |
| Net Income (Loss) Attributable to ParentUSD | — | 385,802Source | -271,476Source | -467,297Source | -42,664Source | 825,611Source | -303,364Source | 599,215Source |
| Additional Financial Items | ||||||||
| General and Administrative ExpenseUSD | — | 324,864Source | 197,060Source | 509,857Source | 1,518Source | 309,994Source | 231,509Source | 1,350,078Source |
| Gain (Loss) on Investments | — | — | — | — | —Source | — | — | — |
| Nonoperating Income (Expense) | — | — | — | — | — | —Source | —Source | — |